Moreno MU - Search Results

1

HIF-1-mediated up-regulation of cardiotrophin-1 is involved in the survival response of cardiomyocytes to hypoxia.

Robador PA, San José G, Rodríguez C, Guadall A, Moreno MU, Beaumont J, Fortuño A, Díez J, Martínez-González J, Zalba G. Robador PA, et al. Among authors: moreno mu. Cardiovasc Res. 2011 Nov 1;92(2):247-55. doi: 10.1093/cvr/cvr202. Epub 2011 Jul 19. Cardiovasc Res. 2011. PMID: 21771897

2

Potential role of microRNA-10b down-regulation in cardiomyocyte apoptosis in aortic stenosis patients.

Gallego I, Beaumont J, López B, Ravassa S, Gómez-Doblas JJ, Moreno MU, Valencia F, de Teresa E, Díez J, González A. Gallego I, et al. Among authors: moreno mu. Clin Sci (Lond). 2016 Dec 1;130(23):2139-2149. doi: 10.1042/CS20160462. Epub 2016 Sep 13. Clin Sci (Lond). 2016. PMID: 27624142

3

Preliminary characterisation of the promoter of the human p22(phox) gene: identification of a new polymorphism associated with hypertension.

Moreno MU, San José G, Orbe J, Páramo JA, Beloqui O, Díez J, Zalba G. Moreno MU, et al. FEBS Lett. 2003 May 8;542(1-3):27-31. doi: 10.1016/s0014-5793(03)00331-4. FEBS Lett. 2003. PMID: 12729892 Free article.

4

Functional effect of the p22phox -930A/G polymorphism on p22phox expression and NADPH oxidase activity in hypertension.

San José G, Moreno MU, Oliván S, Beloqui O, Fortuño A, Díez J, Zalba G. San José G, et al. Among authors: moreno mu. Hypertension. 2004 Aug;44(2):163-9. doi: 10.1161/01.HYP.0000134790.02026.e4. Epub 2004 Jun 21. Hypertension. 2004. PMID: 15210651 Free article. Clinical Trial.

5

NADPH oxidase-mediated oxidative stress: genetic studies of the p22(phox) gene in hypertension.

Zalba G, San José G, Moreno MU, Fortuño A, Díez J. Zalba G, et al. Among authors: moreno mu. Antioxid Redox Signal. 2005 Sep-Oct;7(9-10):1327-36. doi: 10.1089/ars.2005.7.1327. Antioxid Redox Signal. 2005. PMID: 16115038 Free article. Review.

6

The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension.

Moreno MU, San José G, Fortuño A, Beloqui O, Díez J, Zalba G. Moreno MU, et al. J Hypertens. 2006 Jul;24(7):1299-306. doi: 10.1097/01.hjh.0000234110.54110.56. J Hypertens. 2006. PMID: 16794479

7

A novel CYBA variant, the -675A/T polymorphism, is associated with essential hypertension.

Moreno MU, San José G, Fortuño A, Beloqui O, Redón J, Chaves FJ, Corella D, Díez J, Zalba G. Moreno MU, et al. J Hypertens. 2007 Aug;25(8):1620-6. doi: 10.1097/HJH.0b013e3281ac211d. J Hypertens. 2007. PMID: 17620958 Free article.

8

The angiotensin-converting enzyme insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent superoxide generation: potential implication in hypertension.

San José G, Fortuño A, Moreno MU, Robador PA, Bidegain J, Varo N, Beloqui O, Díez J, Zalba G. San José G, et al. Among authors: moreno mu. Clin Sci (Lond). 2009 Feb;116(3):233-40. doi: 10.1042/CS20080057. Clin Sci (Lond). 2009. PMID: 18647135 Free article.

9

CYBA gene variants as biomarkers for coronary artery disease.

Moreno MU, Zalba G. Moreno MU, et al. Drug News Perspect. 2010 Jun;23(5):316-24. doi: 10.1358/dnp.2010.23.5.1437711. Drug News Perspect. 2010. PMID: 20603655 Free article. Review.

10

Protective effect of the 1742(C/G) polymorphism of human cardiotrophin-1 against left ventricular hypertrophy in essential hypertension.

Robador PA, Moreno MU, Beloqui O, Varo N, Redón J, Fortuño A, Zalba G, Díez J. Robador PA, et al. Among authors: moreno mu. J Hypertens. 2010 Nov;28(11):2219-26. doi: 10.1097/HJH.0b013e32833da326. J Hypertens. 2010. PMID: 20683337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters